4//SEC Filing
Bruns Ingmar 4
Accession 0001725160-25-000037
CIK 0001725160other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 6:30 PM ET
Size
7.4 KB
Accession
0001725160-25-000037
Insider Transaction Report
Form 4
Bruns Ingmar
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-03+16,629→ 16,629 totalExercise: $1.68Exp: 2035-02-02→ Common Stock (16,629 underlying) - Award
Common Stock
2025-02-03+16,629→ 16,629 total
Footnotes (2)
- [F1]Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a two year period following the grant date, subject to the Reporting Person's continued service with the Issuer.
- [F2]The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.
Documents
Issuer
Zentalis Pharmaceuticals, Inc.
CIK 0001725160
Entity typeother
Related Parties
1- filerCIK 0001838041
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 6:30 PM ET
- Size
- 7.4 KB